The rap video that makes you want to book a smear test!
Ladies! And anyone with a cervix! I recommend getting screened for cervical cancer if you can. In the UK this is at age 25 and older, and if the results are clear you only have to go back again every three years.
Here’s the storify of Nadia Kamil live-tweeted appointment.
Video published on 7 Apr 2014 by Nadia Kamil‘s channel.
‘I know it’s weird to show strangers your foof!’: The rap video that makes you want to book a smear test. Now, telegraph, 11 Apr 2014.
Watch @DES_Journal diaporama and health posters album on Flickr.
” This winter 2015 there is a battle between those who care for people and those who only care about profits. We have to save the NHS from the greed & corruption of private companies who wish to sacrifice one of the greatest institutions of our country, recognised globally as the most cost-effective and efficient health service in the world. ” Sources: 999callfornhs.
” Their boobs are painted with words that best describe #whatnormalfeelslike for them. We want you ladies to reclaim the vocabulary surrounding boobs and get to know what your boobs look and feel like normally.
Keep your eyes peeled because these ads will be coming to a magazine, billboard and shop changing room near you! ”
Did suicide warnings around antidepressants cause more suicide?
To investigate if the widely publicized warnings in 2003 from the US Food and Drug Administration about a possible increased risk of suicidality with antidepressant use in young people were associated with changes in antidepressant use, suicide attempts, and completed suicides among young people.
Quasi-experimental study assessing changes in outcomes after the warnings, controlling for pre-existing trends.
Automated healthcare claims data (2000-10) derived from the virtual data warehouse of 11 health plans in the US Mental Health Research Network.
Study cohorts included adolescents (around 1.1 million), young adults (around 1.4 million), and adults (around 5 million).
Main outcome measures
Rates of antidepressant dispensings, psychotropic drug poisonings (a validated proxy for suicide attempts), and completed suicides.
Trends in antidepressant use and poisonings changed abruptly after the warnings. In the second year after the warnings, relative changes in antidepressant use were −31.0% (95% confidence interval −33.0% to −29.0%) among adolescents, −24.3% (−25.4% to −23.2%) among young adults, and −14.5% (−16.0% to −12.9%) among adults. These reflected absolute reductions of 696, 1216, and 1621 dispensings per 100 000 people among adolescents, young adults, and adults, respectively. Simultaneously, there were significant, relative increases in psychotropic drug poisonings in adolescents (21.7%, 95% confidence interval 4.9% to 38.5%) and young adults (33.7%, 26.9% to 40.4%) but not among adults (5.2%, −6.5% to 16.9%). These reflected absolute increases of 2 and 4 poisonings per 100 000 people among adolescents and young adults, respectively (approximately 77 additional poisonings in our cohort of 2.5 million young people). Completed suicides did not change for any age group.
Safety warnings about antidepressants and widespread media coverage decreased antidepressant use, and there were simultaneous increases in suicide attempts among young people. It is essential to monitor and reduce possible unintended consequences of FDA warnings and media reporting.
Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study, BMJ 2014;348:g3596, 18 June 2014.
Communicating the harmful effects of medicines, BMJ 2014; 348 bmj.g4047, 18 June 2014.
Did suicide warnings around antidepressants cause more suicide? a tweet from Ben Goldacre.
A convincing sales pitch appeared in 1957, right in the middle of the thirty-three year period between 1938 and 1971 during which Diethylstilbestrol (DES) was prescribed regularly under various brand names
“Yes! desPLEX to prevent abortion miscarriage and premature labor. Recommended for routine prophylaxis in ALL pregnancies! Ninety-six percent live delivery with desPLEX in one series of 1200 patients – bigger and stronger babies, too. No gastric or other side effects with desPLEX – in either high or low dosage.”
This convincing sales pitch appeared in 1957, right in the middle of the thirty-three year period between 1938 and 1971 during which Diethylstilbestrol (DES) was prescribed regularly under the brand names Estrosyn, Palestrol, Domestrol, and more.